Joel C Exebio, Sahar Ajabshir, Adriana Campa, Tan Li, Gustavo G Zarini, Fatma G Huffman
{"title":"补充维生素D对2型糖尿病少数民族血脂的影响","authors":"Joel C Exebio, Sahar Ajabshir, Adriana Campa, Tan Li, Gustavo G Zarini, Fatma G Huffman","doi":"10.23937/2377-3634/1410093","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Vitamin D deficiency and type 2 diabetes are common among Hispanics and African Americans in the US. The aim of the study was to determine the effect of supplemental vitamin D intake (4000 IU/day or 6000 IU/day of vitamin D3 over a 6-month period) on blood lipids in a sample of African Americans and Hispanics with type 2 diabetes and vitamin D insufficiency.</p><p><strong>Materials and methods: </strong>Participants (n = 75) were recruited by community outreach. Participants in both groups were required to take either 4000 IU or 6000 IU of vitamin D (Cholecalciferol) per day given in the form of a pill in a single daily dose. Mixed model was used to compare treatment effects (4000 IU vs. 6000 IU) on the outcome variables. Bonferroni multiple comparison test was used to detect significant changes from baseline, 3 months, and 6 months.</p><p><strong>Results: </strong>A significant decrease in total cholesterol (from 193.88 ± 41.03 to 180.48 ± 27.53 mg/dl, <i>P</i> = 0.040) and triglycerides (from 201.44 ± 91.35 to 172.92 ± 76.87 mg/dl, <i>P</i> = 0.037) was found for the 6000 IU group at 6 months. The significance was lost after adjusting for confounders.</p><p><strong>Conclusion: </strong>Our results suggest that the positive effect of vitamin D supplementation on lipid profile may be mediated by other cofactors related to vitamin D metabolism among Hispanic and African American participants with type 2 diabetes.</p>","PeriodicalId":92797,"journal":{"name":"International journal of diabetes and clinical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731032/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Effect of Vitamin D Supplementation on Blood Lipids in Minorities with Type 2 Diabetes.\",\"authors\":\"Joel C Exebio, Sahar Ajabshir, Adriana Campa, Tan Li, Gustavo G Zarini, Fatma G Huffman\",\"doi\":\"10.23937/2377-3634/1410093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Vitamin D deficiency and type 2 diabetes are common among Hispanics and African Americans in the US. The aim of the study was to determine the effect of supplemental vitamin D intake (4000 IU/day or 6000 IU/day of vitamin D3 over a 6-month period) on blood lipids in a sample of African Americans and Hispanics with type 2 diabetes and vitamin D insufficiency.</p><p><strong>Materials and methods: </strong>Participants (n = 75) were recruited by community outreach. Participants in both groups were required to take either 4000 IU or 6000 IU of vitamin D (Cholecalciferol) per day given in the form of a pill in a single daily dose. Mixed model was used to compare treatment effects (4000 IU vs. 6000 IU) on the outcome variables. Bonferroni multiple comparison test was used to detect significant changes from baseline, 3 months, and 6 months.</p><p><strong>Results: </strong>A significant decrease in total cholesterol (from 193.88 ± 41.03 to 180.48 ± 27.53 mg/dl, <i>P</i> = 0.040) and triglycerides (from 201.44 ± 91.35 to 172.92 ± 76.87 mg/dl, <i>P</i> = 0.037) was found for the 6000 IU group at 6 months. The significance was lost after adjusting for confounders.</p><p><strong>Conclusion: </strong>Our results suggest that the positive effect of vitamin D supplementation on lipid profile may be mediated by other cofactors related to vitamin D metabolism among Hispanic and African American participants with type 2 diabetes.</p>\",\"PeriodicalId\":92797,\"journal\":{\"name\":\"International journal of diabetes and clinical research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731032/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of diabetes and clinical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2377-3634/1410093\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/9/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of diabetes and clinical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2377-3634/1410093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/9/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言:维生素 D 缺乏症和 2 型糖尿病在美国西班牙裔和非洲裔美国人中很常见。该研究旨在确定补充维生素 D 摄入量(每天 4000 IU 或每天 6000 IU 的维生素 D3,为期 6 个月)对患有 2 型糖尿病和维生素 D 不足的非裔美国人和西班牙裔美国人血脂的影响:通过社区宣传招募参与者(75 人)。两组参与者都必须每天服用 4000 IU 或 6000 IU 的维生素 D(胆钙化醇),每天服用一次。混合模型用于比较治疗效果(4000 IU 与 6000 IU)对结果变量的影响。采用 Bonferroni 多重比较检验检测基线、3 个月和 6 个月的显著变化:结果:6 个月时,6000 IU 组的总胆固醇(从 193.88 ± 41.03 mg/dl 降至 180.48 ± 27.53 mg/dl,P = 0.040)和甘油三酯(从 201.44 ± 91.35 mg/dl 降至 172.92 ± 76.87 mg/dl,P = 0.037)明显下降。结论:我们的研究结果表明,6000 IU 组在 6 个月内对降血脂有积极作用:我们的研究结果表明,在患有 2 型糖尿病的西班牙裔和非裔美国人中,维生素 D 补充剂对血脂状况的积极影响可能是由与维生素 D 代谢有关的其他辅助因子介导的。
The Effect of Vitamin D Supplementation on Blood Lipids in Minorities with Type 2 Diabetes.
Introduction: Vitamin D deficiency and type 2 diabetes are common among Hispanics and African Americans in the US. The aim of the study was to determine the effect of supplemental vitamin D intake (4000 IU/day or 6000 IU/day of vitamin D3 over a 6-month period) on blood lipids in a sample of African Americans and Hispanics with type 2 diabetes and vitamin D insufficiency.
Materials and methods: Participants (n = 75) were recruited by community outreach. Participants in both groups were required to take either 4000 IU or 6000 IU of vitamin D (Cholecalciferol) per day given in the form of a pill in a single daily dose. Mixed model was used to compare treatment effects (4000 IU vs. 6000 IU) on the outcome variables. Bonferroni multiple comparison test was used to detect significant changes from baseline, 3 months, and 6 months.
Results: A significant decrease in total cholesterol (from 193.88 ± 41.03 to 180.48 ± 27.53 mg/dl, P = 0.040) and triglycerides (from 201.44 ± 91.35 to 172.92 ± 76.87 mg/dl, P = 0.037) was found for the 6000 IU group at 6 months. The significance was lost after adjusting for confounders.
Conclusion: Our results suggest that the positive effect of vitamin D supplementation on lipid profile may be mediated by other cofactors related to vitamin D metabolism among Hispanic and African American participants with type 2 diabetes.